New computational model reveals novel possibilities for H. pylori treatment

December 6, 2013 by John David Pastor
New computational model reveals novel possibilities for H. pylori treatment
Adria Carbo reviews computer models for the H. pylori experiment

A new computational model developed by researchers at the Center for Modeling Immunity to Enteric Pathogens at Virginia Tech's Virginia Bioinformatics Institute offers new ways to study host immune responses to the gastric ulcer-causing bacterium Helicobacter pylori.

Using the model, researchers identified an abnormal linked to development of lesions during H. pylori of the stomach. Their findings may help clinicians pinpoint how best to treat such infections.

"This large-scale of host responses to H. pylori infection combines cutting-edge approaches in computational modeling and experimental research to help elucidate immune responses to H. pylori," said Raquel Hontecillas, co-director of the center, which is part of Virginia Tech's Nutritional Immunology and Molecular Medicine Laboratory.

H. pylori lives in the human gut and sometimes causes ulcers and cancers. Currently, doctors treat H. pylori infections with antibiotics that destroy the bacteria. However, H. pylori also can protect against diseases such as asthma, obesity and diabetes. Understanding how a harmless bacterial population becomes virulent and leads to disease has been difficult, but the computational model developed by the center researchers has led to new insights.

Based on results from experimental work with mouse models, the team of scientists built a computational simulation that can predict how and when infection begins and progresses. The model shows the position of cells during infection and accounts for the non-uniformity and randomness of immune responses.

Using the computational model, laboratory researchers found that, although H. pylori may be responsible for starting an infection, abnormal immune responses can contribute to chronic ulcers or cancers.

"The knowledge gained from such models will accelerate the development of novel drugs and vaccines for H. pylori-associated diseases," said Hontecillas. "The ultimate aim may not be to destroy H. pylori but to learn how to manipulate the interaction of the bacterium and host immune system to produce beneficial effects."

More information: Carbo A, Bassaganya-Riera J, Pedragosa M, Viladomiu M, Marathe M, et al. (2013) Predictive Computational Modeling of the Mucosal Immune Responses during Helicobacter pylori Infection. PLoS ONE 8(9): e73365. DOI: 10.1371/journal.pone.0073365

Related Stories

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.